199 related articles for article (PubMed ID: 21062768)
21. Cardiac challenges in patients with Fabry disease.
Weidemann F; Linhart A; Monserrat L; Strotmann J
Int J Cardiol; 2010 May; 141(1):3-10. PubMed ID: 19720409
[TBL] [Abstract][Full Text] [Related]
22. Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes.
Adalsteinsdottir B; Palsson R; Desnick RJ; Gardarsdottir M; Teekakirikul P; Maron M; Appelbaum E; Neisius U; Maron BJ; Burke MA; Chen B; Pagant S; Madsen CV; Danielsen R; Arngrimsson R; Feldt-Rasmussen U; Seidman JG; Seidman CE; Gunnarsson GT
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28798024
[TBL] [Abstract][Full Text] [Related]
23. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
[TBL] [Abstract][Full Text] [Related]
25. Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy.
Ackerman MJ; Landstrom AP
J Am Coll Cardiol; 2007 Dec; 50(25):2404-5. PubMed ID: 18154966
[No Abstract] [Full Text] [Related]
26. Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results.
Linthorst GE; Poorthuis BJ; Hollak CE
J Am Coll Cardiol; 2008 May; 51(21):2082; author reply 2082-3. PubMed ID: 18498967
[No Abstract] [Full Text] [Related]
27. Electrocardiographic changes in early recognition of Fabry disease.
Namdar M; Steffel J; Vidovic M; Brunckhorst CB; Holzmeister J; Lüscher TF; Jenni R; Duru F
Heart; 2011 Mar; 97(6):485-90. PubMed ID: 21270075
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R
Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550
[TBL] [Abstract][Full Text] [Related]
29. Late-onset Fabry disease: the cardiac sequela.
Tremblay J; Kim S; Philbin E; Beers K; Lightle A; Belov D
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35680278
[TBL] [Abstract][Full Text] [Related]
30. Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke.
Brouns R; Sheorajpanday R; Braxel E; Eyskens F; Baker R; Hughes D; Mehta A; Timmerman T; Vincent MF; De Deyn PP
Clin Neurol Neurosurg; 2007 Jul; 109(6):479-84. PubMed ID: 17509753
[TBL] [Abstract][Full Text] [Related]
31. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
33. Cardiac magnetic resonance imaging in patients with Fabry's disease.
Małek LA; Chojnowska L; Spiewak M; Kłopotowski M; Miśko J; Petryka J; Miłosz B; Ruzyłło W
Kardiol Pol; 2010 Aug; 68(8):929-34. PubMed ID: 20730727
[TBL] [Abstract][Full Text] [Related]
34. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
[TBL] [Abstract][Full Text] [Related]
35. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
[TBL] [Abstract][Full Text] [Related]
36. Targeted urine microscopy in Anderson-Fabry disease: a cheap, sensitive and specific diagnostic technique.
Selvarajah M; Nicholls K; Hewitson TD; Becker GJ
Nephrol Dial Transplant; 2011 Oct; 26(10):3195-202. PubMed ID: 21382994
[TBL] [Abstract][Full Text] [Related]
37. α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.
Oder D; Liu D; Hu K; Üçeyler N; Salinger T; Müntze J; Lorenz K; Kandolf R; Gröne HJ; Sommer C; Ertl G; Wanner C; Nordbeck P
Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29018006
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.
Nagao Y; Nakashima H; Fukuhara Y; Shimmoto M; Oshima A; Ikari Y; Mori Y; Sakuraba H; Suzuki Y
Clin Genet; 1991 Mar; 39(3):233-7. PubMed ID: 1645238
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping.
Deborde E; Dubourg B; Bejar S; Brehin AC; Normant S; Michelin P; Dacher JN
Diagn Interv Imaging; 2020 Feb; 101(2):59-67. PubMed ID: 31519470
[TBL] [Abstract][Full Text] [Related]
40. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]